Inflazyme Pharmaceuticals Ltd.: Orexo AB Shareholders Approve Acquisition of Biolipox AB

Published: Nov 14, 2007

VANCOUVER, BRITISH COLUMBIA--(Marketwire - November 13, 2007) - Inflazyme Pharmaceuticals Ltd. (TSX: IZP) today announced that the shareholders of Orexo AB (OMX Nordic List, Mid Cap:ORX) have approved the acquisition of Biolipox AB. The new entity has retained the name Orexo and the President and CEO of Biolipox, Dr. Torbjorn Bjerke, will be formally appointed as the President and CEO of the new entity once the transaction is closed.

Back to news